A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)

NCT07365371 · clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
174
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Collaborators